Linfoma de Burkitt: revisión bibliográfica y estudio clínico, morfológico y viral de 9 casos cubanos

Le Riverend, Eloisa; Rengifo, Enrique; Ruiz, Relman; Longchong, Marta; Portero Urquizo, Alfredo; Valdés, Marta; Castro, Manuel; Gurtsevich, Vladimir.
Rev. cuba. pediatr ; 59(4): 623-34, jul.-ago. 1987. mapas, tab
Artículo en Español | LILACS | ID: lil-53250

Documentos relacionados

  1. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
  2. Epstein‒Barr virus-associated cellular immunotherapy.
  3. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
  4. Hybridization of Burkitt lymphoblastoid cells.
  5. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells.
  6. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
  7. The Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old Enigma.
  8. Activation of Epstein-Barr virus in hybrid cells.
  9. Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
  10. Burkitt's lymphoma with 2/8 translocation: a case report with special reference to the clinical features.